PT Lippo Karawaci Tbk (LPKR.JK)

Indonesia · Healthcare · IDR

Key financials

ROE: 1.57%; 2025 (actual)
ROA: 0.91%; 2025 (actual)
Gross Margin: 33.73%; 2025 (actual)
Net Margin: 5.31%; 2025 (actual)
Total Assets: IDR 49,247.22B; 2025 (actual)
Net Income: IDR 469.54B; 2025 (actual)
Valuation: IDR 5,952.02B; 2025 (actual)
Stock Price: IDR 84; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	1.57%	1.81%	2.26%	2.96%	3.64%	3.93%
Sector average	9.61%	8.15%	4.43%	106.09%	9.11%	-15.92%
ROA	0.91%	1.07%	1.21%	1.39%	1.53%	1.57%
Sector average	5.93%	6.11%	5.79%	5.8%	5.77%	5.49%
Gross Margin	33.73%	33.73%	33.73%	33.73%

Amounts in IDR (billions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for PT Lippo Karawaci Tbk? It covers the balance sheet, income statement and Equlion model projections.

Net Margin	5.31%	5.47%	5.88%	6.68%	7.49%	7.87%
Sector average	6.04%	6.25%	6.16%	6.45%	6.8%	6.99%

Total Assets	IDR 49,247.22B	IDR 53,289.08B	IDR 62,674.73B	IDR 73,511.12B	IDR 82,749.16B	IDR 87,990.07B
Sector average	IDR 7,353B	IDR 7,871.2B	IDR 8,776.94B	IDR 9,968.98B	IDR 11,181.14B	IDR 12,214.16B

Net Income	IDR 469.54B	IDR 549.97B	IDR 701.34B	IDR 943.77B	IDR 1,197.72B	IDR 1,342.46B
Sector average	IDR 335.05B	IDR 361.91B	IDR 409.48B	IDR 499.3B	IDR 586.99B	IDR 641.74B

Valuation	IDR 5,952.02B	IDR 6,244.03B	IDR 6,537.21B	IDR 6,806.9B	IDR 7,055.44B	IDR 7,325.97B
Sector average	IDR 14,416.13B	IDR 19,376B	IDR 20,324.94B	IDR 20,030.02B	IDR 18,971.81B	IDR 18,513.18B

Stock Price	IDR 84	IDR 88.12	IDR 92.26	IDR 96.06	IDR 99.57	IDR 103.39
Sector average	IDR 2,059.43	IDR 1,839.21	IDR 1,924.82	IDR 1,903.8	IDR 1,818.04	IDR 1,784.88